在第4阶段的开放性干预研究中,患者报告的辅助布雷克西普拉在重度抑郁症中的有效性
François Therrien1, Pratap Chokka2,3, Jeffrey Habert4
1Otsuka Canada Pharmaceutical Inc., Saint-Laurent, Quebec, Canada.
Current medical research and opinion
|September 6, 2025
概括
在8周的时间里,补充布雷克西普拉显著改善了患者报告的抑郁症严重程度和重大抑郁症 (MDD) 的发生. 患者日记,包括一个
科学领域:
- 精神病学
- 临床心理学
- 药理学
背景情况:
- 大型抑郁症 (MDD) 显著影响患者的幸福感和日常功能.
- 对于对标准抗抑郁药物治疗反应不足的患者,辅助治疗至关重要.
- 患者报告的结局提供了对治疗疗效和实践经验的宝贵见解.
研究的目的:
- 通过ENGAGE研究的日记数据分析患者对辅助布雷克斯皮普拉的看法.
- 评估辅助布雷克斯皮普拉对抑郁症严重程度和生活参与度的影响.
- 描述临床试验中的"当天的词"活动的发展和实用性.
主要方法:
- 来自8周的开放性ENGAGE研究 (NCT04830215) 患者日记数据的分析.
- 包括患者的整体印象 - 严重程度 (PGI-S) 和改善 (PGI-I) 尺度.
- 使用"当天的词"活动来捕捉每天的患者情绪.
主要成果:
- 从基线到第8周的PGI- S得分显著改善 (p < 0. 001).
- 患者报告PGI- I的"微小改善"到"大改善".
- 在"当天的词"活动中增加了积极/中立词的比例,减少了负面词.
结论:
- 在患者报告的抑郁症状中,补充布雷克西普拉显示出早期和持续的改善.
- 患者报告的结果证实了布雷克斯皮普拉在提高生活参与度方面的有效性.
- "当天的词"是评估患者在试验中的经验的有价值的定性工具.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
337
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
337
Drugs for Treatment of Constipation-Predominant IBS
322
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
322
Interpersonal Psychotherapy
97
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
97
Dipeptidyl Peptidase 4 Inhibitors
249
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
249
Psychosis: Goals of Pharmacotherapy
208
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
208


